MDBriefCase
MDBriefCase is a Toronto-headquartered digital CME/CPD platform, founded in 2004 and a subsidiary of Think Research, that delivers free accredited continuing education courses, webinars, and a weekly newsletter to 285,000+ physicians, pharmacists, nurses, and allied health professionals across Canada, Australia, the Middle East, the UK, and Europe.
- Company typePrivate
- Founded2004
- HeadquartersToronto, Canada
- Headcount1–10
- GTM typeB2C
- OfferingDigital Commerce or Content
What MDBriefCase does
MDBriefCase is a Toronto-based digital continuing medical education (CME/CPD) platform founded in 2004 that provides free, accredited on-demand courses to physicians, pharmacists, nurses, and allied health professionals across Canada, Australia, the Middle East (notably Saudi Arabia), the UK, and Europe. The core product is a web-based learning management system delivering content through eCME modules, video lectures, expert briefs, microlearnings (5–20 minutes), interactive quizzes, animations, webinars, and downloadable resources across therapeutic areas including cardiovascular disease, diabetes, mental health, dermatology, menopause, oncology, and respiratory medicine.
The underlying technology is a multi-format LMS with regional content adaptation and integration into national accreditation systems: Mainpro+ via the College of Family Physicians of Canada (CFPC), Canadian Council on Continuing Education in Pharmacy (CCCEP) accreditation for pharmacists, and parallel accreditation via RACGP (Australia), RCGP (UK), and SCFHS (Saudi Arabia). Content is co-developed and peer-reviewed with 30+ medical associations and universities (Queens University, University of Alberta, University of Manitoba, Sunnybrook Health Sciences Centre, Canadian Thoracic Society, Obesity Canada, MHCC, among others), and delivered in English and French. The platform operates a sub-brand ecosystem including RxBriefCase (pharmacy), RxNow (real-time pharmacy updates), Postcall (weekly newsletter, 15,000+ Canadian clinician subscribers), and OncologyEducation.
MDBriefCase operates a freemium/end-user-free business model. All course content is provided at no cost to clinicians; revenue is generated primarily through unrestricted educational grants and sponsorships from pharmaceutical and medical device companies that fund branded or therapeutic-area CME modules, with secondary revenue from advertising placements on the Postcall newsletter. The company is a wholly-owned subsidiary of Think Research, a strategic operating company that also owns Pharmapod, OncologyEducation, and related clinical-decision-support assets. Headcount, revenue figures, and detailed financial disclosures are not publicly available.
MDBriefCase firmographics
Firmographics- Name
- MDBriefCase
- Legal name
- MDBriefCase
- Website
- https://mdbriefcase.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- MDBriefCase is a Toronto-headquartered digital CME/CPD platform, founded in 2004 and a subsidiary of Think Research, that delivers free accredited continuing education courses, webinars, and a weekly newsletter to 285,000+ physicians, pharmacists, nurses, and allied health professionals across Canada, Australia, the Middle East, the UK, and Europe.
- Ownership category
- akta.pro rank
MDBriefCase industry classification
Industry- Product category
- Continuing Medical Education
- NAICS
- Newspaper, Periodical, Book, and Directory Publishers (5131), Software Publishers (5132)
- SIC
- Miscellaneous Publishing (2741)
- akta.pro primary industry
- Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)
- akta.pro secondary industries
- Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy) (EDAAALAC), Medicine & Allied Health (Clinical) (EDAGABAG), Healthcare & Life Sciences (EDAAAPAA)
Keywords
Where MDBriefCase is headquartered
LocationHeadquarters
- HQ city
- Toronto
- HQ country
- Canada
- HQ region
- North America
Markets served
MDBriefCase business model
Business model- GTM type
- B2C
- Offering type
- Digital Commerce or Content
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Pharmaceutical Educational Grants: The primary revenue model consists of unrestricted educational grants and sponsorships from pharmaceutical and medical device companies. These companies fund specific educational programs in exchange for having their products or therapeutic areas featured within accredited CME content.
- Advertising - Postcall Newsletter: The Postcall newsletter monetizes its 15,000+ subscriber base through sponsored content placements from healthcare brands.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Pay-as-you-go | Free access to all CME/CPD content |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
MDBriefCase product offering
Product offeringCore offering
MDBriefCase operates a digital continuing medical education (CME/CPD) platform that delivers free, accredited on-demand courses, live webinars, microlearnings, expert briefs, and clinical updates to physicians, pharmacists, nurses, and allied health professionals across Canada, Australia, the Middle East, the UK, and Europe. Content is developed with more than 30 global medical partner institutions and accredited through Mainpro+/CFPC, CCCEP, RACGP, RCGP, and other regional bodies. Revenue is generated through unrestricted pharmaceutical educational grants and newsletter sponsorships rather than user fees.
Product overview
MDBriefCase is a multi-platform continuing medical education ecosystem providing accredited CME/CPD courses for physicians, pharmacists, nurses, and allied healthcare professionals. The core MDBriefCase platform offers on-demand courses, live webinars, microlearning modules, expert briefs, and video content across 11+ therapeutic areas (cardiovascular, diabetes, mental health, dermatology, women's health, etc.). The ecosystem includes complementary sub-brands: Postcall (weekly medical newsletter for Canadian clinicians), RxBriefcase (pharmacy-specific learning), RxNow (real-time pharmacy updates), OncologyEducation (oncology education), and Pharmapod (pharmacy safety). Content is developed with 40+ global medical partners and is entirely free for users, with Mainpro+ and other regional accreditation.
Differentiator
Problem solved
Functional benefit
Brands
- RxBriefcase: MDBriefCase's pharmacy-focused continuing education learning platform
- Postcall
- RxNow
Products and services
- MDBriefCase CME/CPD Platform Core digital learning platform providing free accredited CME/CPD courses, live webinars, microlearning modules, expert briefs, video content, and downloadable resources across 11+ therapeutic areas (cardiovascular, diabetes, mental health, dermatology, oncology, respirology, paediatrics, etc.) for physicians, pharmacists, nurses, and allied health professionals in Canada, Australia, the Middle East, the UK, and Europe.
- RxBriefcase Pharmacy-focused continuing education platform offering accredited courses, CCCEP-accredited CE credits, and clinical updates specifically designed for pharmacists.
- Postcall Newsletter Weekly newsletter 'Canadian medicine's must-know newsletter' delivering high-yield medicine summaries, clinical insights, and medical news to 15,000+ Canadian clinicians, with sponsored content placements from healthcare brands.
- RxNow Real-time continuing education content and updates resource hub for pharmacists and healthcare professionals.
- HTA Workshop Series for Saudi Arabia Multi-module health economics and pharmacoeconomics workshop program aligned with Saudi Food and Drug Authority (SFDA) requirements for health technology assessment submissions, targeting HTA professionals in Saudi Arabia.
Quantifiable outcome
- 285,000+ healthcare professionals worldwide rely on MDBriefCase for continuing education
- +2 more outcomes
Companies that use MDBriefCase
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles2 records
MDBriefCase technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
MDBriefCase partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core and major.
- College of Family Physicians of Canada (CFPC)corePrimary accreditation partner for Canadian family physicians. MDBriefCase courses are certified for Mainpro+ credits through CFPC and Quebec College of Family Physicians.
- Royal Australian College of General Practitioners (RACGP)coreAccreditation partner for Australian general practitioners. Courses are adapted and certified for Australian CME requirements.
- Royal College of General Practitioners (RCGP) - UKcoreUK-based accreditation partner for continuing professional development for general practitioners.
- Queens UniversitymajorAcademic partnership for medical education content development and review.
- University of AlbertamajorAcademic partnership for medical education content development.
- University of ManitobamajorAcademic partnership for medical education content development.
- Sunnybrook Health Sciences CentremajorAcademic hospital partnership for clinical content development and expert faculty.
- Canadian Thoracic SocietymajorProfessional society partnership for respiratory and pulmonary medicine content.
- Obesity CanadamajorPartnership for obesity management and metabolic health educational content.
- Mental Health Commission of Canada (MHCC)majorPartnership for mental health education and awareness content.
- Saudi Food and Drug Authority (SFDA) / MOHcoreHTA training programs for Saudi Arabian market, aligned with SFDA requirements for health technology assessment submissions.
- Think ResearchcoreParent company providing clinical decision support tools and connected ecosystem including RxBriefCase, Pharmapod, and OncologyEducation.
Scale indicators5 records
Recent moves5 records
Expansion highlights5 records
MDBriefCase competitors and assessment
Company assessmentDirect peers
- Medscape: WebMD-owned Medscape is the largest global digital CME provider for physicians, offering free accredited continuing education funded by pharma sponsorship — the same freemium, grant-monetized model that MDBriefCase operates.
- Clinical Care Options: Clinical Care Options produces accredited CME/CE activities for physicians, pharmacists, and nurses funded by educational grants from pharma, overlapping directly with MDBriefCase's target audience and revenue model.
- Pri-Med: Pri-Med provides free CME/CE for primary care clinicians through online and in-person channels, including pharma-supported programming — a directly comparable primary care-focused CME platform.
- ProCE: ProCE is an accredited provider of continuing pharmacy education, directly comparable to MDBriefCase's RxBriefcase subsidiary for pharmacist-targeted accredited CE.
- CE City: CE City provides accredited continuing education tracking and delivery for healthcare professionals, comparable to MDBriefCase's platform in serving the CE/CME credit accumulation workflow.
- ACHL (Academy for Continued Healthcare Learning): ACHL is an ACCME-accredited provider of pharma-funded CME/CE across multiple therapeutic areas, competing with MDBriefCase for the same clinician audiences and pharma sponsorships.
Broad incumbents
- HealthStream: HealthStream is a publicly traded healthcare workforce education and training company that addresses a related but broader enterprise compliance and clinical education market versus MDBriefCase's free, clinician-direct CME.
- UpToDate: Wolters Kluwer's UpToDate is a clinical decision support and learning platform used by clinicians globally, adjacent to MDBriefCase's CME offering but broader in scope and primarily sold via institutional licenses rather than free, grant-funded CME.
- DynaMed: EBSCO's DynaMed is a clinician reference and decision-support tool that competes for the same clinician mindshare as MDBriefCase's expert briefs and CME content, with a broader portfolio and institutional sales model.
- Haymarket Media: Haymarket Media's medical division produces pharma-funded medical education, journals, and CME, comparable to MDBriefCase in its grant-funded clinician education model but operating at significantly greater scale across multiple global brands.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
MDBriefCase social profiles
Digital presenceMDBriefCase compliance and trust
Trust signalCompliance2 records
MDBriefCase financial estimates
Financial estimateRevenue estimate
Valuation estimate
MDBriefCase leadership team
Management profileNumber of profiles
MDBriefCase subsidiaries and ownership
Company hierarchySubsidiaries2 records
MDBriefCase funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MDBriefCase M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MDBriefCase
What does MDBriefCase do?
MDBriefCase operates a digital continuing medical education (CME/CPD) platform that delivers free, accredited on-demand courses, live webinars, microlearnings, expert briefs, and clinical updates to physicians, pharmacists, nurses, and allied health professionals across Canada, Australia, the Middle East, the UK, and Europe. Content is developed with more than 30 global medical partner institutions and accredited through Mainpro+/CFPC, CCCEP, RACGP, RCGP, and other regional bodies. Revenue is generated through unrestricted pharmaceutical educational grants and newsletter sponsorships rather than user fees.
Is MDBriefCase a public or private company?
MDBriefCase is a private company. It is classified as corporate owned and is currently operating.
When was MDBriefCase founded?
MDBriefCase was founded in 2004. It employs 1 to 10 people.
Where is MDBriefCase based?
MDBriefCase is headquartered in Toronto, Canada, in the North America region.
How does MDBriefCase make money?
Two revenue lines are on record. Pharmaceutical Educational Grants are the primary driver. The others are advertising - Postcall Newsletter.
Who are MDBriefCase's main competitors?
Direct peers on record are Medscape, Clinical Care Options, Pri-Med, ProCE, CE City and ACHL (Academy for Continued Healthcare Learning). Broad incumbents are HealthStream, UpToDate, DynaMed and Haymarket Media.
Does MDBriefCase have an API?
No public API is recorded for MDBriefCase.
What industry is MDBriefCase in?
MDBriefCase's product category is Continuing Medical Education. Its primary akta.pro industry code is EDAGANAJ, Healthcare & Clinical Professional Development (CME/CE), with a secondary code of EDAAALAC, Healthcare Clinical Professions (CME/CE for Nurses, Allied Health, Pharmacy). Its NAICS code is 5131 and its SIC code is 2741.